Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001736243-18-000003
Filing Date
2018-05-31
Accepted
2018-05-31 15:13:05
Documents
1
Effectiveness Date
2018-05-31
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6473
  Complete submission text file 0001736243-18-000003.txt   7498
Mailing Address 22 CAMELOT COURT WHITE PLAINS NY 10603
Business Address 22 CAMELOT COURT WHITE PLAINS NY 10603 914-949-3898
Acurx Pharmaceuticals, LLC (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-309165 | Film No.: 18871232